Rudolf A. Heijtink

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

Harry L.A. Janssen, Guido Gerken, Vicente Carréño et al. · Hepatology · 1999 · 152 citations · Full text

Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates

R. del Canho, P.M. Grosheide, S W Schalm et al. · Journal of Hepatology · 1994 · 111 citations

Vaccination, Maternal Immunization, Infectious Disease Prevention +10

Conversion of 2′,3′‐dideoxyadenosine (ddA) and 2′,3′‐didehydro‐2′,3′‐dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus

Jan Balzarini, J. Kruining, Orson Wedgwood et al. · FEBS Letters · 1997 · 60 citations · Full text

Immunology, Cell Culture, Antiviral Drug +21

Measurement of HBsAg to monitor hepatitis B viral replication in patients on α-interferon therapy

Harry L.A. Janssen, Coby J. Kerhof-Los, Rudolf A. Heijtink et al. · Antiviral Research · 1994 · 54 citations

Viral Persistence, Hepatology, Viral Hepatitis +7

Spontaneous Disappearance of Viral Replication and Liver Cell Inflammation in Hbsag–Positive Chronic Active Hepatitis: Results of A Placebo Vs. Interferon Trial

Solko W. Schalm, Rudolf A. Heijtink · Hepatology · 1982 · 45 citations · Full text